Mutational analysis of FANCL, FANCM and FANCI fanconi anemia genes in high-risk non-BRCA1/BRCA2 breast cancer families

被引：0
|
作者：
Garcia, Maria [1 ]
Fernandez, Victoria [1 ]
Osorio, Ana [1 ]
Barroso, Alicia [1 ]
Urioste, Miguel [1 ]
Benitez, Javier [1 ]
机构：
[1] Spanish Nacl Canc Res Ctr CNIO, Madrid, Spain
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4331
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition
    Garcia, Maria J.
    Fernandez, Victoria
    Osorio, Ana
    Barroso, Alicia
    Fernandez, Fernando
    Urioste, Miguel
    Benitez, Javier
    CARCINOGENESIS, 2009, 30 (11) : 1898 - 1902
  • [2] Mutational analysis of the breast cancer susceptibility gene BRIP1/BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families
    Frédéric Guénard
    Yvan Labrie
    Geneviève Ouellette
    Charles Joly Beauparlant
    Jacques Simard
    Francine Durocher
    Journal of Human Genetics, 2008, 53
  • [3] Mutational analysis of the breast cancer susceptibility gene BRIP1 /BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families
    Guenard, Frederic
    Labrie, Yvan
    Ouellette, Genevieve
    Beauparlant, Charles Joly
    Simard, Jacques
    Durocher, Francine
    JOURNAL OF HUMAN GENETICS, 2008, 53 (07) : 579 - 591
  • [4] Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis
    Blanche P. Alter
    Ana F. Best
    Breast Cancer Research and Treatment, 2020, 182 : 465 - 476
  • [5] Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis
    Alter, Blanche P.
    Best, Ana F.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 182 (02) : 465 - 476
  • [6] Correction to: Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis
    Blanche P. Alter
    Ana F. Best
    Breast Cancer Research and Treatment, 2020, 183 : 491 - 491
  • [7] Transcriptional signature of lymphoblastoid cell lines of BRCA1, BRCA2 and non-BRCA1/2 high risk breast cancer families
    Pouliot, Marie-Christine
    Kothari, Charu
    Joly-Beauparlant, Charles
    Labrie, Yvan
    Ouellette, Genevieve
    Simard, Jacques
    Droit, Arnaud
    Durocher, Francine
    ONCOTARGET, 2017, 8 (45) : 78691 - 78712
  • [8] Non-BRCA1/BRCA2 high-risk familial breast cancers are not associated with a high prevalence of BRCAness
    Andersen, Lars v. B.
    Larsen, Martin J.
    Davies, Helen
    Degasperi, Andrea
    Nielsen, Henriette Roed
    Jensen, Louise A.
    Kroeldrup, Lone
    Gerdes, Anne-Marie
    Laenkholm, Anne-Vibeke
    Kruse, Torben A.
    Nik-Zainal, Serena
    Thomassen, Mads
    BREAST CANCER RESEARCH, 2023, 25 (01)
  • [9] Non-BRCA1/BRCA2 high-risk familial breast cancers are not associated with a high prevalence of BRCAness
    Lars v. B. Andersen
    Martin J. Larsen
    Helen Davies
    Andrea Degasperi
    Henriette Roed Nielsen
    Louise A. Jensen
    Lone Kroeldrup
    Anne-Marie Gerdes
    Anne-Vibeke Lænkholm
    Torben A. Kruse
    Serena Nik-Zainal
    Mads Thomassen
    Breast Cancer Research, 25
  • [10] Analysis of polymorphisms in genes encoding proteins interacting with BRCA1 in high-risk non-BRCA1/2 families
    Guenard, F
    Labrie, Y
    Ouellette, G
    Houde, M
    Simard, J
    Durocher, F
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 231 - 231
12345